Antonio Carballo García

ORCID: 0000-0003-3363-0415 · 2 papers in corpus
article 2025
·doi:10.1016/j.maturitas.2025.108441
review 2025
Biomedicines ·doi:10.3390/biomedicines13081851

Background: Uterine fibroids (UFs) and endometriosis are gynecological conditions that significantly increase morbidity among women of reproductive age. Relugolix, a novel gonadotropin-releasing hormone receptor antagonist, is approved in c…